Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             218 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Ability of tumor proliferative activity to predict response to adjuvant chemotherapy with perioperative CEF in stage I–II breast cancer Pronzato, P.
1994
30 S1 p. S24-
1 p.
artikel
2 Accelerated-intensified CEF chemotherapy with the support of GM-CSF and erythropoietin (Epo) Venturini, M.
1994
30 S1 p. S26-
1 p.
artikel
3 Acid and basic fibroblast growth factors and their relationship to vascular density Winstanley, J.
1994
30 S1 p. S6-
1 p.
artikel
4 Acute leukemia in elderly. Treatment with oral idarubicin Musso, M.
1994
30 S1 p. S37-
1 p.
artikel
5 Adjuvant postoperative radiotherapy in cancer of the rectum. Report on 146 cases with 3-year minimum follow up Marzano, S.
1994
30 S1 p. S29-
1 p.
artikel
6 Administration of an anti-interleukin-6 monoclonal antibody to patients with aids and lymphoma Emilie, D.
1994
30 S1 p. S44-
1 p.
artikel
7 A five drug regimen for intermediate and high grade NHL De Renzo, A.
1994
30 S1 p. S39-
1 p.
artikel
8 Age, menopausal status, histological grade, surgical stage and surgical clearance: Indipendent prognostic factors in epithelial ovarian cancer Panoskaltsis, T.A.
1994
30 S1 p. S42-
1 p.
artikel
9 Alterations of parenchymal α1-adrenergic receptors in human lung adenocarcinoma Kond ratenko, T.
1994
30 S1 p. S34-
1 p.
artikel
10 Altering tumorigenicity and invasive properties by treatment with 5-azacytidine Vinvals, A.
1994
30 S1 p. S5-
1 p.
artikel
11 A multicentric phase II study with l-folinic acid (FA), fluorouracil (F), escalating doses of epirubicin (E), cyclophoshamide (C) plus G-CSF in advanced breast cancer (ABC) Colucci, G.
1994
30 S1 p. S24-
1 p.
artikel
12 Anal function after low anterior resection in rectal cancer Ceccopieri, B.
1994
30 S1 p. S30-
1 p.
artikel
13 Analogues of CB 1954 as substrates for DT diaphorase Quinn, J.
1994
30 S1 p. S8-
1 p.
artikel
14 A new affinity chromatography support for isolation of tumor-associated antigens from colon cancer tumors and sera of tumor-bearing rats Zusman, I.
1994
30 S1 p. S31-
1 p.
artikel
15 An immunomodulatory role for taurine in hostantt-tumor defence Finneean, N.
1994
30 S1 p. S11-
1 p.
artikel
16 A novel approach to the study of control mechanism of angiogenesis Hu, D.E.
1994
30 S1 p. S3-
1 p.
artikel
17 A novel P53 germline mutation associated with a familial brain tumour syndrome Lübbe, J.
1994
30 S1 p. S4-
1 p.
artikel
18 Anti-estrogenic therapy in metastatic colo-rectal cancer Dornschneider, G.
1994
30 S1 p. S7-
1 p.
artikel
19 Anti-idiotypic antibodies for immunization against tumor associated antigens in humans Fagerber, J.
1994
30 S1 p. S11-
1 p.
artikel
20 Antitumoral activity of the new antiestrogen RU 58668 on the human mammary cell line MCF-7 Planchoni, P.
1994
30 S1 p. S8-
1 p.
artikel
21 Aortic infusion (5-FU, MMC, CDDP) and stop-flow (MMC, ADM) for systemically pretreated and progressive FIGO III c and IV ovarian cancer Gailhofer, S.
1994
30 S1 p. S41-
1 p.
artikel
22 Arterial endothelium (ED) damage caused by 5-fluorouracil (5-FU) infusion may responsible for angina of colorectal cancer patients — animal model study Lai, G.M.
1994
30 S1 p. S29-
1 p.
artikel
23 A survey of the management of breast cancer in England and Wales Harries, S.A.
1994
30 S1 p. S21-
1 p.
artikel
24 Asymptomatic patients with inoperable localized non-small cell lung cancer: Radiotherapy now or later? Ampil, F.L.
1994
30 S1 p. S32-
1 p.
artikel
25 Azidothymidine (AZT), 5-fluorouracil (5-FU) and l-folinic acid (FA): A pilot study in metastatic colorectal cancer (MCRC) Falcone, A.
1994
30 S1 p. S28-
1 p.
artikel
26 BCL-2 expression is related to metastatic potential in breast cancer Sierra, A.
1994
30 S1 p. S26-
1 p.
artikel
27 Brain metastases from breast cancer: Predictive factors for long-time survival Nieder, C.
1994
30 S1 p. S23-
1 p.
artikel
28 Breast cancer, desmoid tumours and familial adenomatous polyposis coli — A unifying hypothesis Benson, J.R.
1994
30 S1 p. S1-
1 p.
artikel
29 Breast cancer detection by Tc-99m MIBI mammoscintigraphy Lastoria, S.
1994
30 S1 p. S21-
1 p.
artikel
30 Breast cancer: Influence of age on treatment choice of surgeon and radiation oncologist De Winter, K.
1994
30 S1 p. S19-
1 p.
artikel
31 Breast cancer in less than 36 years of age patients. Clinique sainte-catherine experience Vuillemin, E.
1994
30 S1 p. S25-
1 p.
artikel
32 Breast carcinoma: The prognostic relevance of ER.R factor in association with pS2 and c-erbB-2 status Gotteland, M.
1994
30 S1 p. S20-
1 p.
artikel
33 CA 15-3 ceruloplasmin (CRL) and tissue polypeptide specific antigen (TPS) as tour markers in female breast cancer Ozyilkan, O.
1994
30 S1 p. S23-
1 p.
artikel
34 Can breast reconstruction with gel-filled silicone implant increase the risk of death and second primary cancer in patients treated by mastectomy for breast cancer? Rietjens, M.
1994
30 S1 p. S24-
1 p.
artikel
35 CEA, MCA and CA 15.3 as independent prognostic factors (IPF) in primary breast cancer Moraglio, L.
1994
30 S1 p. S23-
1 p.
artikel
36 Cell cycle characteristics of CD34+ hematopoietic stem cells (HSC) after FEC chemotherapy + colony-stimulating factors (CSF's) Danova, M.
1994
30 S1 p. S2-
1 p.
artikel
37 Characterization of egf receptors (EGFR) in primary brain tumors of adults and children Bondiau, P.Y.
1994
30 S1 p. S1-
1 p.
artikel
38 Cisplatin and treosulfane chemotherapy in the treatment of metastatic ovarian cancer Bähr, I.
1994
30 S1 p. S41-
1 p.
artikel
39 Cisplatin and treosulfane chemotherapy in the treatment of metastatic ovarian cancer -low versus high dose Merkle, E.
1994
30 S1 p. S42-
1 p.
artikel
40 C-kit proto-oncogene and stem cell factor in germ cell tumors: Preferential coexpression in seminomas Izquierdo, M.A.
1994
30 S1 p. S3-
1 p.
artikel
41 Clinic, morphologic and biologic characterization of 69 consecutive cases of large-bowel carcinomas Fante, R.
1994
30 S1 p. S28-
1 p.
artikel
42 Clones of a human ovarian cancer cell lines expressing wild-type or mutated as a model for studying new anticancer agents Broggini, M.
1994
30 S1 p. S7-
1 p.
artikel
43 Colorectal cancer: A 10-year surgical experience Setty Carraro, P.
1994
30 S1 p. S30-
1 p.
artikel
44 Combined chemotherapy in pleurectomized malignant pleural mesothelioma patients Hastürk, S.
1994
30 S1 p. S34-
1 p.
artikel
45 Comparison among seric, immunohistochemical and radio immuno guided surgery (RIGS) detection of CEA and B 72.3 in colorectal carcinomas De Marco, L.
1994
30 S1 p. S28-
1 p.
artikel
46 Concomitant adjuvant chemotherapy with FNC regimen and radiotherapy for stage II breast carcinoma: A feasibility study Serin, D.
1994
30 S1 p. S25-
1 p.
artikel
47 Conservative treatment for in situ ductal carcinoma Candiani, E.
1994
30 S1 p. S18-
1 p.
artikel
48 Control of malignant pleural effusions in breast cancer: A randomized trial of bleomycin versus interferon alfa Vietti-Ramus, G.
1994
30 S1 p. S27-
1 p.
artikel
49 Cyclophosphamide-cisplatin/CPM-CDDP/versus cyclophosphamide-carboplatin/CPM-CPL/ with and without antiemetic zofran in the treatment of advanced ovarian cancer/ST.III–IV. Krommer, K.
1994
30 S1 p. S42-
1 p.
artikel
50 Detection of clonal T cell population in peripheral blood of patients with cutaneous malignant T-cell lymphoma Staib, G.
1994
30 S1 p. S40-
1 p.
artikel
51 Detection of PR and KI-67 in paraffin-embedded tissue: A comparison with fresh tissue results De Marco, L.
1994
30 S1 p. S19-
1 p.
artikel
52 Diagnostic efficiency of computerised tomography (CT) and serum Ca-125 levels after intra-peritoneal chemotherapies (IPC) in patients with ovarian carcinoma Topuz, E.
1994
30 S1 p. S43-
1 p.
artikel
53 Differential metabolic fate of octadecyl-methyl-alycero-3-phosohocholine (ET18-OMe) in tumoral cells, normal cells and isolated and oerfused liver Magistrelli, A.
1994
30 S1 p. S8-
1 p.
artikel
54 2′,2′,-Difluorodeoxycytmine and interferon-α against human renal cell carcinoma in nude mice Rohde, D.
1994
30 S1 p. S8-
1 p.
artikel
55 Distribution of HLA-DRB alleles in breast cancer patients differs from this one in healthy donors Togo, A.V.
1994
30 S1 p. S26-
1 p.
artikel
56 DNA ploidy by image analysis (CAS-200) in ovarian cancer Tzirakis, A.
1994
30 S1 p. S43-
1 p.
artikel
57 Dolichol as a tumour marker in ovarian cancer control Kuznetsovs, S.
1994
30 S1 p. S42-
1 p.
artikel
58 Dose-dependent dissociation of effects of 5aza CdR on growth and differentiation of the human leukemic cell line U-937 Attadia, V.
1994
30 S1 p. S36-
1 p.
artikel
59 Dose-response effect to epirubicin (EPI) in patients (PTS) with advanced breast cancer (ABC) Vici, P.
1994
30 S1 p. S26-
1 p.
artikel
60 Early tumour cell dissemination in non-small cell lung cancer Pantel, K.
1994
30 S1 p. S35-
1 p.
artikel
61 Ecographic evaluation of capsule thickness after radical mastectomy with prosthetic reconstruction for breast cancer Cressa, C.
1994
30 S1 p. S18-
1 p.
artikel
62 Effect of filgrastim on granulocytopenia induced by chemotherapy in patients with multiple myeloma Pogòd, R.
1994
30 S1 p. S11-
1 p.
artikel
63 Effect of inhalant fungotherapy on lewis lung carcinoma spreading in mice Kuznetsovs, S.
1994
30 S1 p. S11-
1 p.
artikel
64 Effects of the activated Ki-ras expression on thyroid epithelial cells in vivo and in vitro Califano, D.
1994
30 S1 p. S4-
1 p.
artikel
65 Efficacy of mitoxantron in treatment of tumor's pleurisy and ascites Abashin, S.U.
1994
30 S1 p. S7-
1 p.
artikel
66 Epidemiological, virological and clinico-pathological data from 114 patients(pts) with Hedgkin's disease and HIV infection (HD-HIV) Errante, D.
1994
30 S1 p. S38-
1 p.
artikel
67 Epidermal growth factor receptor in bile duct cancer and hepatolithiasis King-Teh, Lee
1994
30 S1 p. S3-
1 p.
artikel
68 Ether phospholipids and AZA-derivatives as new anti-neoplastic drugs Principe, P.
1994
30 S1 p. S37-
1 p.
artikel
69 Evaluation of prognostic factors with respect to survival of colorectal cancer patients Ozyilkan, O.
1994
30 S1 p. S30-
1 p.
artikel
70 Evaluation of serum tissue polypeptide specific antigen levels in breast cancer patients Hou, Hing-Fens
1994
30 S1 p. S23-
1 p.
artikel
71 Expression of P53 in cirrhotic livers adjacent to hepatocellular carcinoma Livni, N.
1994
30 S1 p. S4-
1 p.
artikel
72 Expression of sicam-1 in urine and serum of bladder cancer patients: A useful marker? Rohde, D.
1994
30 S1 p. S12-
1 p.
artikel
73 Expression of TGFβ isoforms in breast cancer MacCallum, J.
1994
30 S1 p. S21-
1 p.
artikel
74 Extracutaneous clonal TcR-Beta rearrangement on cutaneous T-cell lymphoma (CTCL) and T-Pseudolymphomas (PSL) Dommann, S.N.W.
1994
30 S1 p. S38-
1 p.
artikel
75 Factors affecting outcome of patients with impalpable breast cancers Ravi Sekar, O.
1994
30 S1 p. S24-
1 p.
artikel
76 Favourable survival outcome in patients with SCLC treated by sequential intensive chemotherapy and high dose chest irradiation Chella, A.
1994
30 S1 p. S33-
1 p.
artikel
77 Fecal high butyrate production of clinical relevance with plantago ovata seeds (POS) Jahnig,
1994
30 S1 p. S29-
1 p.
artikel
78 FEC vs high dose fec in the treatment of advanced breast cancer Brugnatelli, S.
1994
30 S1 p. S18-
1 p.
artikel
79 Five-days administration of cisplatin and vepesid in inoperable non small cells lung cancer (NSCLC) Sogno, G.
1994
30 S1 p. S35-
1 p.
artikel
80 Food and colorectal adenomatous polyps. A multicenter Hospital-based-case-control study in southern Italy Centonze, S.
1994
30 S1 p. S13-
1 p.
artikel
81 Genetic and physiologic considerations in radiotherapy of breast cancer Dvořák, E.
1994
30 S1 p. S20-
1 p.
artikel
82 Glioma polyposis (turcot syndrome): A case report of a rare hereditary disorder Maier-Hauff, K.
1994
30 S1 p. S4-
1 p.
artikel
83 Haemostatic changes; plasma levels of alpha2-antiplasmin-plasmin complex (APP) and thrombin-antithrombin III complex (TAT) in female breast cancer Ozyilkan, O.
1994
30 S1 p. S23-
1 p.
artikel
84 Herec-alfa TNF and INF-alfa combination therapy in patients with lymphoma malignum Muc, M.
1994
30 S1 p. S39-
1 p.
artikel
85 High dose epidoxorubicin (EPIDX) and lonidamine (LND) in patients (PTS) with refractory or recurrent epithelial ovarian carcinoma (EOC) Brunetti, I.
1994
30 S1 p. S41-
1 p.
artikel
86 High dose epirusicin (HD-Epl) and cyclophosphamide (CTX) every two weeks + r-met-HuG-CSF in locally advanced (LABC) and metastatic breast cancer (MBC) Del Blanco, S.
1994
30 S1 p. S18-
1 p.
artikel
87 High-dose rate brachyerapy (HDR-BT) for endobronchial lung carcinoma: Results and complications in 111 patients (PTS) Reboul, F.
1994
30 S1 p. S35-
1 p.
artikel
88 High risk breast cancer patients: An intensive adjuvant regimen administered with or without G-CSF Batdini, E.
1994
30 S1 p. S17-
1 p.
artikel
89 HLA-a-linked locus D6S265 is associated with increased susceptibility to common acute lymphoblastic leukaemia Dorak, M.T.
1994
30 S1 p. S2-
1 p.
artikel
90 Homozygosity for HLA-A∗0301 reveals a high risk for young-onset chronic myeloid leukaemia (CML) Dorak, M.T.
1994
30 S1 p. S2-
1 p.
artikel
91 How to overcome the problem of nipple and areola involvement in central small size breast cancer? Zanini, V.
1994
30 S1 p. S27-
1 p.
artikel
92 Hyperfractionated accelerated radiotherapy combined with alpha-2 interferon in the treatment of non small cell lung cancer Paraskevaides, M.
1994
30 S1 p. S35-
1 p.
artikel
93 Hyperfractionated radiation therapy (HFX RT) with and without concurrent chemotherapy (CT) for stage III non-small cell lung cancer (NSCLC) Jeremic, B.
1994
30 S1 p. S34-
1 p.
artikel
94 Idarubicin, carboplatin, vinorelbina, prednisone in relapsed and resistent lymphomas Musso, M.
1994
30 S1 p. S39-
1 p.
artikel
95 Identification of subjects at risk for colorectal carcinoma through a screening test on DNA derived from stool Dugani, A.
1994
30 S1 p. S31-
1 p.
artikel
96 Immunogenotypic and immunophenotipic studies in cutaneous T cell lymphoma Mateu, R.
1994
30 S1 p. S39-
1 p.
artikel
97 Immunohistochemical evaluation of P53-gene expression in patients with non-Hodgkin's lymphoma: Correlation to histological subtype and EBV-status Houmand, A.
1994
30 S1 p. S39-
1 p.
artikel
98 Importance of cellular proliferation markers in predicting the clinical course of patients affected by lung carcinoma Adami, F.
1994
30 S1 p. S32-
1 p.
artikel
99 In breast tissues, somatostatin-14 receptor ratio: 57 kD / 42kD is independent of previous described tumour markers Salle, V.
1994
30 S1 p. S14-
1 p.
artikel
100 Indomethacin inhibits growth of a highly tumorigenic breast cancer cell-line independently from prostaglandin Planchon, P.
1994
30 S1 p. S24-
1 p.
artikel
101 Inflammatory breast cancer: Combined therapy with chemotherapy plus lonidamine, surgery and radiotherapy de Matteis, A.
1994
30 S1 p. S19-
1 p.
artikel
102 Influence of TGF β1 and chemotherapy on cytokine secretion in SCLC Fischer, J.R.
1994
30 S1 p. S11-
1 p.
artikel
103 In-home supportive therapy and LD-ARA-C for high risk acute leukemic elderly patients Abbadessa, A.
1994
30 S1 p. S36-
1 p.
artikel
104 Intensive chemotherapy with high dose epirubicin (EPI)in advanced breast cancer. the experience of the hellenic co-operative oncology group (HeCOG) Athanassiadis, A.
1994
30 S1 p. S16-
1 p.
artikel
105 Interferon alpha enhances the cytotoxicity of cytosine arabinoside in HL60 cells by increasing apoptosis and is synergistic with cytosine arabinoside in clinical combination treatment regimens Bezwoda, W.R.
1994
30 S1 p. S10-
1 p.
artikel
106 Interferon and 5-FU in advanced colorectal cancer Bhowmik, K.T.
1994
30 S1 p. S28-
1 p.
artikel
107 Interleukin-2 (IL-2) and alpha-2 Interferon in metastatic renal cell carcinoma (MRCC): Analysis of 22 cases Landatio, G.
1994
30 S1 p. S11-
1 p.
artikel
108 IntrapleuralrIL-2 pleural effusions due to malignant mesothelioma Castapneto, B.
1994
30 S1 p. S10-
1 p.
artikel
109 Is there a surgeon-related influence on long term prognosis after resection of colorectal cancer? Schwenk, W.
1994
30 S1 p. S30-
1 p.
artikel
110 Italian programmes against smoking Arciti, C.
1994
30 S1 p. S13-
1 p.
artikel
111 Local recurrence of breast cancer after radical mastectomy: Biological and pathological parameters Lombardi, C.P.
1994
30 S1 p. S21-
1 p.
artikel
112 Long-term evaluation of the five-day plan to stop smoking (FDP) in northeastern Italy Serraino, D.
1994
30 S1 p. S14-
1 p.
artikel
113 Low-dose 6-S leucovorin (LLV) AND 5-fluorouracil (5-FU) as salvage treatment in metastatic breast cancer (MBC) Zaniboni, A.
1994
30 S1 p. S27-
1 p.
artikel
114 Lymph node metastases predict short-term distant recurrence in locally advanced breast cancer (LABC) treated by preoperative chemotherapy Both, C.
1994
30 S1 p. S17-
1 p.
artikel
115 Margin status evaluation in breast carcinoma treated with primary chemotherapy and conservative surgery Botti, C.
1994
30 S1 p. S17-
1 p.
artikel
116 May histopathological subgroups offer prognostic indication in infiltrating lobular carcinoma of the breast? Zunarelli, E.
1994
30 S1 p. S27-
1 p.
artikel
117 Measurement of genetic damage in colorectal tumors by DNA fingerprinting Peinado, M.A.
1994
30 S1 p. S30-
1 p.
artikel
118 Mechanism of action of a benzoylnitrogen mustard derivative of distamycin (FCE24617) Damia, G.
1994
30 S1 p. S7-
1 p.
artikel
119 Membrane vesicles recovered from the ascitic fluid of human ovarian cancer patients, contain collagenases and tumour associated antigens Dolo, V.
1994
30 S1 p. S41-
1 p.
artikel
120 Methemoglobinemia determination by HPLC method in breast cancer della Rovere, F.
1994
30 S1 p. S19-
1 p.
artikel
121 Methotrexate, mitoxantrone, fluorouracil and leucovorin (MMFL) in metastatic breast cancer patients (PTS) Mammoliti, S.
1994
30 S1 p. S22-
1 p.
artikel
122 Mice: A new active combination for NSCLC Arcangeli, G.
1994
30 S1 p. S32-
1 p.
artikel
123 Microvessel count (MC) and tumor vessel invasion in non small cell lung cancer (NSCLC): Correlation with nodal involvement and late-state disease Fontanini, G.
1994
30 S1 p. S33-
1 p.
artikel
124 Milk intake and breast cancer incidence Knekt, P.
1994
30 S1 p. S14-
1 p.
artikel
125 Mitomycin, methotrexate and mitoxantrone (3M) for the second line treatment of metastatic breast carcinoma Santoro, A.
1994
30 S1 p. S25-
1 p.
artikel
126 Modulation of MDR1, c-erb-B2 and p53 expression by chemotherapy in locally advanced breast cancer Schneider, J.
1994
30 S1 p. S5-
1 p.
artikel
127 Molecular epidemiological study on ethylene exposed population Ember, I.
1994
30 S1 p. S2-
1 p.
artikel
128 Monocyte functions following treatment with colony stimulating factors in patients with advances testicular cancer undergoing autologous bone arrow transplantation Wiltschke, Christoph
1994
30 S1 p. S5-
1 p.
artikel
129 MPV (Mitomycin c, cisplatin, vinblastine) neoadjuvant chemotherapy in the treatment of stage III non small cell lung cancer Chiesa, G.
1994
30 S1 p. S33-
1 p.
artikel
130 Mutations in two sets of bladder cancer patients Kannio, A.
1994
30 S1 p. S3-
1 p.
artikel
131 Natural history of breast cancer (new proposals to early detection) Semiglazov, Y.F.
1994
30 S1 p. S25-
1 p.
artikel
132 Natural killer activity (NBA) in patients with head and neck squamous cell carcinoma (HNSCC) treated with cisplatin (P) /5-fluorouracil (F) +/- interferon 2b (INT) Shparik, J.
1994
30 S1 p. S12-
1 p.
artikel
133 Neoadiuvant chemotherapy with epihin inflammatory breast cancer Butera, A.
1994
30 S1 p. S18-
1 p.
artikel
134 New in vitro approach for individualization of treatment in children with acute leukemia (AL) Metelitsa, L.
1994
30 S1 p. S8-
1 p.
artikel
135 Non palpable breast lesions: Analysis of 952 operated cases Sacchini, V.
1994
30 S1 p. S16-
1 p.
artikel
136 Novel analogues of CB 1954: Their potential use in antibody directed enzyme prodrug therapy (ADEPT) Somani, H.H.
1994
30 S1 p. S9-
1 p.
artikel
137 N-ras & c-myc expression induces cddp resistance in human melanoma cell lines van der Heyden, S.
1994
30 S1 p. S5-
1 p.
artikel
138 One-stage emergency curative treatment of colonic obstruction versus elective curative treatment of colon cancer: Compared analysis of survival and recurrence patterns Setti Carraro, P.
1994
30 S1 p. S31-
1 p.
artikel
139 Overexpression of the oncogene C-ERBB-2 in ovarian cancer: A new prognostic factor Meden, H.
1994
30 S1 p. S42-
1 p.
artikel
140 Overexpression of the p53 tumor suppressor gene in myeloid leukemic K562 cells Ehinger, M.
1994
30 S1 p. S2-
1 p.
artikel
141 P53 and pGp expressions in acute leukemia Seyrek, E.
1994
30 S1 p. S37-
1 p.
artikel
142 407 patients (pts) with AIDS-related non-Hodgkin's lymphoma (AIDS-NHL): The experience of the GICAT (Italian Cooperative Group on AIDS and Tumors) with emphasis on the prospective treatment of 93 pts at a single institution Tirelli, U.
1994
30 S1 p. S40-
1 p.
artikel
143 Phase II study of cisplatin (CDDP), ifosfamide (IFX) and vinorelbine (VNR) in stage-IIIB-IV NSCLC Baldini, E.
1994
30 S1 p. S33-
1 p.
artikel
144 Phase II study of epirubicin (EPI) and lonidamine (LND) in advanced breast cancer Martini, M.C.
1994
30 S1 p. S22-
1 p.
artikel
145 Photodynamic therapy and/or endobronchial irradiation as pretreatment in external radiation therapy for patients with inoperable non-small cell lung cancer: An interim analysis Baas, P.
1994
30 S1 p. S33-
1 p.
artikel
146 Photodynamic therapy for superficial cutaneous mammary metastases using photofrin Baas, P.
1994
30 S1 p. S16-
1 p.
artikel
147 Photodynamic therapy of gynecological tumors with antibody guided Zn-Phthalocyanin Schmidt, S.
1994
30 S1 p. S43-
1 p.
artikel
148 Physiopathology, clinical and molecular oncology interest for several loci on human chromosome SP Bendayan, H.J.
1994
30 S1 p. S1-
1 p.
artikel
149 Platinum-etoposide (PE) chemoradiation for stage III inoperable non small-cell lung cancer (NSCLC): Toward an improved local control? Reboul, F.
1994
30 S1 p. S35-
1 p.
artikel
150 Potential value of biilary CEA assay in early detection of liver metastases from colorectal carcinomas Frik, L.
1994
30 S1 p. S29-
1 p.
artikel
151 P53 protein detected by immunohistochemistry in malignant epithelial ovarian tumors Klemi, P.J.
1994
30 S1 p. S42-
1 p.
artikel
152 Preoperative application of interferon inducer on patients with rectal cancer Skvortsova, I.
1994
30 S1 p. S12-
1 p.
artikel
153 Primary breast cancer imaging by Tc-99m MDP scintigraphy Piccolo, S.
1994
30 S1 p. S24-
1 p.
artikel
154 Primary cutaneous B-cell lymphoma (CBCL) Bari, M.
1994
30 S1 p. S38-
1 p.
artikel
155 Prognostic factors in Hodgkin's disease (HD), stage IIA bulky to IV, treated with combined radio-chemotherapy Sorarú, M.
1994
30 S1 p. S40-
1 p.
artikel
156 Prognostic factors in small cell lung cancer Lara Alvarez, Ma.
1994
30 S1 p. S34-
1 p.
artikel
157 Prognostic valence of protein products of the ERB B-gene family in primary breast carcinomas Göhring, U.-J.
1994
30 S1 p. S3-
1 p.
artikel
158 Prognostic value of lymph node involvement >50% after neoadjuvant chemotherapy for locally advanced breast cancer Delva, R.
1994
30 S1 p. S19-
1 p.
artikel
159 Proliferation arrest by exogenous wt p53 is abrogated by mutation or lack of expression in m p53 cell lines Vinyals, A.
1994
30 S1 p. S5-
1 p.
artikel
160 Proliferative activity and p-53 expression in HPV-DNA-positive urinary bladder carcinoma Righi, E.
1994
30 S1 p. S4-
1 p.
artikel
161 ProMICE-CytaBOM chemotherapy in aggressive NHL. A preliminary report Caracciolo, F.
1994
30 S1 p. S38-
1 p.
artikel
162 Proviral sequences of HTLV-I in patients with CTCL Böni, R.
1994
30 S1 p. S2-
1 p.
artikel
163 Radial scars — A screen-detected lesion that must be removed Kissin, M.W.
1994
30 S1 p. S20-
1 p.
artikel
164 Radiation therapy of progressive bronchial carcinoma in 1988–1992 Nestle, U.
1994
30 S1 p. S34-
1 p.
artikel
165 RB and P53 gene product expression in leukemia Sahin, B.
1994
30 S1 p. S37-
1 p.
artikel
166 Reduced mitogenic stimulation of peripheral blood mononuclear cells as a prognostic parameter for the course of breast cancer Krainer, M.
1994
30 S1 p. S21-
1 p.
artikel
167 Regional chemotherapy and breast conservation Michel, P.
1994
30 S1 p. S23-
1 p.
artikel
168 Relationship between mammographic and histological findings in 129 cases of breast lesions Santini, D.
1994
30 S1 p. S25-
1 p.
artikel
169 Resident macrophages do not require dual signal stimulation for tumour cell lysis Duggan, S.
1994
30 S1 p. S10-
1 p.
artikel
170 Resistance to all-trans retinoic acid therapy in acute promyelocytic leukemia: in vitro studies Delva, L.
1994
30 S1 p. S36-
1 p.
artikel
171 Response to oncologic epidemiological questions in under graduate medical students Millán, J.
1994
30 S1 p. S14-
1 p.
artikel
172 Results of chemotherapy combined with involved-field radiotherapy/IF-RT/ for childhood hodgkin's disease/HD/ Balwierz, W.
1994
30 S1 p. S38-
1 p.
artikel
173 Results of different aproach to therapy in adult acute lymphoblastic leukemia Kaletin, G.I.
1994
30 S1 p. S37-
1 p.
artikel
174 Role of combination adjuvant therapy for operable breast cancer Abrams, K.R.
1994
30 S1 p. S16-
1 p.
artikel
175 Secondary leukemia in polycythemia vera patients treated with pipobroman: A Retrospective analysis Spadea, A.
1994
30 S1 p. S15-
1 p.
artikel
176 Second solid tumors in hodgkin disease: Our experience Addamo, G.F.
1994
30 S1 p. S38-
1 p.
artikel
177 Smoking habits and antismoking activities among health personnel in Italy Arciti, C.
1994
30 S1 p. S13-
1 p.
artikel
178 Somatostatin receptor subtype gene expression in breast epithelial cell-lines Veber, N.
1994
30 S1 p. S9-
1 p.
artikel
179 Standard-dose chemotherapy plus G-CSF induces peripheral blood progenitor cells (PBPC) mobilization in breast cancer patients Del Mastro, L.
1994
30 S1 p. S19-
1 p.
artikel
180 Surface electrical potentials as biophisical index of proliferative diseases: Applications to breast cancer diagnosis Merson, M.
1994
30 S1 p. S22-
1 p.
artikel
181 Surgical quality assurance in cancer of the Fallopian tubes and ovaries Uyttenbroeck, F.
1994
30 S1 p. S43-
1 p.
artikel
182 Survival in non small cell lung cancer with malignant pleural effusion Vietti-Ramus, G.
1994
30 S1 p. S35-
1 p.
artikel
183 Synergistic effect of tamoxifen plus the pineal hormone melatonin(MLT) in inhibiting insulin-like growth factor-I (IGF-I)secretion in breast cancer:a biological study Barni, S.
1994
30 S1 p. S17-
1 p.
artikel
184 Tamoxifene and high dose of megestrol acetate in sequential alternate therapy in advanced breast cancer Maiorino, L.
1994
30 S1 p. S22-
1 p.
artikel
185 Testicular non-hodgkin's lymphoma (NHL) Møller, M.B.
1994
30 S1 p. S39-
1 p.
artikel
186 The clinical significance of molecular monitoring in the management of patients with follicular lymphomas Zucca, E.
1994
30 S1 p. S40-
1 p.
artikel
187 The cytotoxic potential of TIMS is mediated through enhanced arginase production Duggan, S.
1994
30 S1 p. S10-
1 p.
artikel
188 The effect of medroxyprogesterone asetat to weight gain and performance status in lung cancer Hastürk, S.
1994
30 S1 p. S33-
1 p.
artikel
189 The influence of progesteron receptors upon the survival of young breast cancer patients Chobanvan, N.S.
1994
30 S1 p. S18-
1 p.
artikel
190 The participation of p 53 oncogene in cervical carcinogenesis Anton, M.
1994
30 S1 p. S1-
1 p.
artikel
191 The role of surgery in the management of the primary gastric non-hodgkin's lymphoma Sigon, R.
1994
30 S1 p. S40-
1 p.
artikel
192 The somatostatin (SST) analogue BIM23014 inhibits growth of the sst receptor (SSTR) positive small cell lung carcinoma (SCLC) xenograft : SCLC-6 Prévost, G.
1994
30 S1 p. S8-
1 p.
artikel
193 The thyroid specific trk oncogene family Greco, A.
1994
30 S1 p. S3-
1 p.
artikel
194 The trip concept: A new synchronized and potentiated neo-adjuyant chemotnerapy by triptorelin (DECAPEPTYL) + insulin and low dose CMF in breast cancer chromosome 8p is usefull Bendavan, H.J.
1994
30 S1 p. S17-
1 p.
artikel
195 The value of bone scanning in the staging of non-small cell lung carcinoma and comparison with the other parameters Arican, A.
1994
30 S1 p. S32-
1 p.
artikel
196 Thyroid cancer: The population registry of ardennesmarne, 1979–1992. Descriptive results and comparison with the other french cancer registries Theobald, S.
1994
30 S1 p. S15-
1 p.
artikel
197 Total rectal resection, colo-anal anastomosis and “J” reservoir in lower third rectal cancer Leo, E.
1994
30 S1 p. S29-
1 p.
artikel
198 Transforming potential of dail oncogene in transgenic mice Monaco, C.
1994
30 S1 p. S4-
1 p.
artikel
199 Treatment of gastrointestinal malignancies with methotrexate (MTX) followed by l-folinic acid (LFA) and 5-fluorouracil (5FU) Palmieri, G.
1994
30 S1 p. S30-
1 p.
artikel
200 Treatment of hairy cell leukemia (HCL) with recombinant interferon (rIFN) and 2-deoxycoformicin (DCF) Lepkov, S.
1994
30 S1 p. S37-
1 p.
artikel
201 Treatment of metastatic breast cancer with triple M chemotherapy Sambataro, L.
1994
30 S1 p. S25-
1 p.
artikel
202 Treatment of metastatic breast cancer with triple M chemotherapy Henke, A.
1994
30 S1 p. S20-
1 p.
artikel
203 Trends in cancer mortality in central european countries: The effect of age, birth cohort and time-period Evsifeeva, T.
1994
30 S1 p. S14-
1 p.
artikel
204 Trends in survival after childhood cancer in Denmark, 1943–1987 Brown, P.N.
1994
30 S1 p. S13-
1 p.
artikel
205 Tumor cell detection in bone marrow of primary breast cancer patient Merkle, E.
1994
30 S1 p. S22-
1 p.
artikel
206 Tumor cell kinetics and tumor vasculature in breast cancer Haustermans, K.
1994
30 S1 p. S20-
1 p.
artikel
207 Tumor markers in lung cancer: Superiority of CYFRA21-1 to CEA and SCC-Ag Nikliński, J.
1994
30 S1 p. S34-
1 p.
artikel
208 Tumour regressions with novel prodrugs in antibody-directed enzyme prodrug therapy (ADEPT) Springer, C.J.
1994
30 S1 p. S9-
1 p.
artikel
209 Turkish cancer mortality statistics Ünalp, A.
1994
30 S1 p. S15-
1 p.
artikel
210 UKCCCR anal cancer trial Houehton, J.
1994
30 S1 p. S29-
1 p.
artikel
211 Ultrasound-guided breast surgery: A novel technique for screen detected impalpable lesions Baildam, A.D.
1994
30 S1 p. S17-
1 p.
artikel
212 Urinary detection of the formation of cyteinyl-leukotrienes in human brain tumor tissues Winking, M.
1994
30 S1 p. S12-
1 p.
artikel
213 Variables in the axilla: New prognostic factors in N+ breast cancer analysis of 1003 cases Zurrida, S.
1994
30 S1 p. S27-
1 p.
artikel
214 VELF: an active outpatient regimen for aggressive metastatic breast cancer (MBC). Preliminary results Meriggi, F.
1994
30 S1 p. S22-
1 p.
artikel
215 Weekly epirubicin in hormone-resistant metastatic breast cancer(MBC) in the elderly Tucci, E.
1994
30 S1 p. S26-
1 p.
artikel
216 What is the risk of invasive tumor in LCIS of the breast? Galimberti, V.
1994
30 S1 p. S20-
1 p.
artikel
217 WT1 function in ovarian tumorigenesis: Possible role of WT1/p53 interaction Viet, A.
1994
30 S1 p. S5-
1 p.
artikel
218 10-Year survival from cancer in Umbria, Italy Mastrandrea, V.
1994
30 S1 p. S14-
1 p.
artikel
                             218 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland